Suchergebnisse - "Engelhardt, Monika"

PubPharm (430)

21

Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

enthalten in: Annals of hematology | 2023

von Wäsch, R. | Strüssmann, T. | Wehr, C. | +4

22

An objective assessment in newly diagnosed multiple myeloma to avoid treatment complications and strengthen therapy adherence

enthalten in: Haematologica | 2023

von Holler, M. | Ihorst, G. | Reinhardt, H. | +8

23

Differences due to socio-economic status, genetic background and sex in cancer and precision medicine - An intersectional approach to close the care gap for marginalized groups

enthalten in: Deutsche medizinische Wochenschrift (1946) | 2023

von Engelhardt, M. | Brioli, A. | von Lilienfeld-Toal, M.

24

Impact of Elotuzumab Plus Pomalidomide/Dexamethasone on Health-related Quality of Life for Patients With Relapsed/Refractory Multiple Myeloma : Final Data From the Phase 2 ELOQUENT-3 Trial

enthalten in: HemaSphere | 2023

von Weisel, K. | Dimopoulos, M. | San-Miguel, J. | +8

25

Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

enthalten in: Annals of hematology | 2023

von Wäsch, R. | Strüssmann, T. | Wehr, C. | +4

26

Safe and successful CAR T-cell therapy targeting BCMA in a multiple myeloma patient requiring hemodialysis

enthalten in: Annals of hematology | 2023

von Wäsch, R. | Strüssmann, T. | Wehr, C. | +4

27

Multidisciplinary tumor board analysis : validation study of a central tool in tumor centers

enthalten in: Annals of hematology | 2023

von Frank, B. | Ihorst, G. | Herget, G. | +13

28

Carfilzomib, lenalidomide, and dexamethasone maintenance for multiple myeloma : when and for whom?

enthalten in: The Lancet. Oncology | 2023

von Engelhardt, M. | Wäsch, R.

CommentOn: Lancet Oncol. 2023 Feb;24(2):139-150. - PMID 36642080

29

Pomalidomide combinations are a safe and effective option after daratumumab failure

enthalten in: Journal of cancer research and clinical oncology | 2023

von Brioli, A. | Gengenbach, L. | Mancuso, K. | +9

30

Pomalidomide combinations are a safe and effective option after daratumumab failure

enthalten in: Journal of cancer research and clinical oncology | 2023

von Brioli, A. | Gengenbach, L. | Mancuso, K. | +9